Pharmacogenetics and Adverse Events in the Use of Fluoropyrimidine in a Cohort of Cancer Patients on Standard of Care Treatment in Zimbabwe.

Afolabi, Boluwatife Lawrence; Mazhindu, Tinashe; Zedias, Chikwambi; Borok, Margaret; Ndlovu, Ntokozo; Masimirembwa, Collen

Afolabi, Boluwatife Lawrence; Mazhindu, Tinashe; Zedias, Chikwambi; Borok, Margaret; Ndlovu, Ntokozo; Masimirembwa, Collen.

Afiliación

Afolabi BL; African Institute of Biomedical Science and Technology, Harare P.O. Box 2294, Zimbabwe.
Mazhindu T; Department of Biotechnology, School of Health Sciences, Chinhoyi University of Technology, Chinhoyi Private Bag 7724, Zimbabwe.
Zedias C; African Institute of Biomedical Science and Technology, Harare P.O. Box 2294, Zimbabwe.
Borok M; Department of Oncology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box 2294, Zimbabwe.
Ndlovu N; African Institute of Biomedical Science and Technology, Harare P.O. Box 2294, Zimbabwe.
Masimirembwa C; Department of Biotechnology, School of Health Sciences, Chinhoyi University of Technology, Chinhoyi Private Bag 7724, Zimbabwe.
On Behalf Of Consortium For Genomics And Therapeutics In Africa Cgta; Department of Oncology, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare P.O. Box 2294, Zimbabwe.

J Pers Med ; 13(4)2023 Mar 28.

Article en En | MEDLINE | ID: mdl-37108974

Palabras clave

adverse drug reactions; cancer; capecitabine; fluorouracil; genetic polymorphism; precision medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Guideline / Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2023 Tipo del documento: Article País de afiliación: Zimbabwe Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google